Correlation Between BioSig Technologies, and Nemaura Medical
Can any of the company-specific risk be diversified away by investing in both BioSig Technologies, and Nemaura Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioSig Technologies, and Nemaura Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioSig Technologies, Common and Nemaura Medical, you can compare the effects of market volatilities on BioSig Technologies, and Nemaura Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioSig Technologies, with a short position of Nemaura Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioSig Technologies, and Nemaura Medical.
Diversification Opportunities for BioSig Technologies, and Nemaura Medical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BioSig and Nemaura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioSig Technologies, Common and Nemaura Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nemaura Medical and BioSig Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioSig Technologies, Common are associated (or correlated) with Nemaura Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nemaura Medical has no effect on the direction of BioSig Technologies, i.e., BioSig Technologies, and Nemaura Medical go up and down completely randomly.
Pair Corralation between BioSig Technologies, and Nemaura Medical
If you would invest 93.00 in Nemaura Medical on November 3, 2024 and sell it today you would earn a total of 0.00 from holding Nemaura Medical or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 5.0% |
Values | Daily Returns |
BioSig Technologies, Common vs. Nemaura Medical
Performance |
Timeline |
BioSig Technologies, |
Nemaura Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
BioSig Technologies, and Nemaura Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioSig Technologies, and Nemaura Medical
The main advantage of trading using opposite BioSig Technologies, and Nemaura Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioSig Technologies, position performs unexpectedly, Nemaura Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nemaura Medical will offset losses from the drop in Nemaura Medical's long position.BioSig Technologies, vs. Neuropace | BioSig Technologies, vs. Inogen Inc | BioSig Technologies, vs. SurModics | BioSig Technologies, vs. Pulmonx Corp |
Nemaura Medical vs. Neuropace | Nemaura Medical vs. CVRx Inc | Nemaura Medical vs. Orthofix Medical | Nemaura Medical vs. Artivion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |